Israeli company Brainsway, which developed a device called Deep TMS (transcranial magnetic stimulation), for treating various brain-related disorders, has announced a successful trial of its treatment for smoking addiction. 84 percent of subjects in the trial quit smoking after receiving the treatment, of which approx. one-third were still non-smokers after a six month period.
Subscribe to NoCamels weekly newsletter and get our top stories
Related posts

Israel Invests Millions To Help AI Comprehend Hebrew, Arabic
September 21, 2023

Cybersecurity Startup Cato Raises $238M With $3B Valuation
September 21, 2023

Israel, UK Ink Deal For Greater Innovation Collaboration
September 21, 2023

ALS Drug Receives Patent In Israel, Europe, Japan
September 20, 2023
Facebook comments